Recent research suggests that medications for type 2 diabetes of the GLP-1 class, such as Ozempic or Mounjaro, could offer an additional benefit beyond glycemic control: reduce the risk of dangerous blood clots in people with diabetes.This finding represents a new potential advantage for those who use these treatments
Zhu L, Baker SS, Liu W, Tao MH, Patel R, Nowak NJ, Baker RD (2011) Lipid in the livers of adolescents with nonalcoholic steatohepatitis: combined effects of pathways on steatosis
With no added chemicals, it offers safe, gentle care
V.YemenS.BorowitzM.LiuL.PlappM.SunF.et al (2010)
Ozempic and Rybelsus are two other brands of semaglutide on the market that are approved by the FDA for glycemic control in diabetes but not for weight management